Great Basin Corporation Appoints Dr. Carlos B. González As Vice President Of Engineering

SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Scientific, Inc. (NASDAQ:GBSN, GBSNU), a molecular diagnostics company, announced today that Carlos B. González, Ph.D. has joined the Company's management team as Vice President of Engineering. González brings more than 20 years of medical device engineering and research experience—including tenure at market leaders such as Abbott and Siemens—to the Utah-based company.

Suggested Articles

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.

Generation Bio filed for a $215 million IPO to advance a pair of gene therapies for liver disease and push one of them into the clinic.

The IPO will push Avidity's lead muscle disorder program through IND-enabling studies and into the clinic in 2021.